Close
0
You have no items in your order cart.
Search
Filters

Vetoryl - 5mg - 30 pack

For the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism (Cushing's disease and syndrome) in dogs.

Active ingredient: Trilostane
Availability: In stock
SKU: 161824
Product tags
Customers who bought this item also bought

VS T4/Cholesterol rotor Test

157154
The T4/Cholesterol Profile is ideal for routine screening of hypothyroidism in dogs and diagnosis of hyperthyroidism in cats, titrating and monitoring patients on thyroid hormone replacement therapy, or patients being treated for hyperthyroid disease.

Librela - 10mg - 2 vials

160794
Librela is the first-of-its-kind veterinary medicine that contains bedinvetmab, a monoclonal antibody that binds to Nerve Growth Factor (NGF), a key player in OA pain and in doing so reduces pain. It functions like naturally occurring antibodies, with minimal involvement of the liver or kidneys in its metabolism and elimination from the body; bedinvetmab also produces minimal gastrointestinal (GI) impact. After one injection of Librela, dogs with osteoarthritis exhibited increased mobility and decreased pain.

Librela - 15mg - 2 vials

160804
Librela is the first-of-its-kind veterinary medicine that contains bedinvetmab, a monoclonal antibody that binds to Nerve Growth Factor (NGF), a key player in OA pain and in doing so reduces pain. It functions like naturally occurring antibodies, with minimal involvement of the liver or kidneys in its metabolism and elimination from the body; bedinvetmab also produces minimal gastrointestinal (GI) impact. After one injection of Librela, dogs with osteoarthritis exhibited increased mobility and decreased pain.

Librela - 20mg - 2 vials

160814
Librela is the first-of-its-kind veterinary medicine that contains bedinvetmab, a monoclonal antibody that binds to Nerve Growth Factor (NGF), a key player in OA pain and in doing so reduces pain. It functions like naturally occurring antibodies, with minimal involvement of the liver or kidneys in its metabolism and elimination from the body; bedinvetmab also produces minimal gastrointestinal (GI) impact. After one injection of Librela, dogs with osteoarthritis exhibited increased mobility and decreased pain.